Edition:
United States

Analysts: Transition Therapeutics Inc (TTHI.OQ)

TTHI.OQ on NASDAQ Stock Exchange Global Market

0.80USD
5 May 2016
Change (% chg)

-- (+0.00%)
Prev Close
$0.80
Open
$0.80
Day's High
$0.80
Day's Low
$0.80
Volume
800
Avg. Vol
10,701
52-wk High
$9.30
52-wk Low
$0.75

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.08 June 5 May 2016

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 2 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 2.50 2.50

Consensus Estimates Analysis

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Jun-16 3 0.00 0.00 0.00 7.91
Year Ending Jun-17 2 0.00 0.00 0.00 13.20
Earnings (per share)
Quarter Ending Mar-16 1 -0.08 -0.08 -0.08 --
Quarter Ending Jun-16 1 -0.08 -0.08 -0.08 --
Year Ending Jun-16 3 -0.38 -0.31 -0.45 -0.85
Year Ending Jun-17 3 -1.20 -0.38 -2.46 -1.22

Historical Surprises

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-15 0.00 0.00 0.00 0.00
Quarter Ending Mar-15 0.00 0.00 0.00 0.00
Quarter Ending Sep-14 0.00 0.00 0.00 0.00
Quarter Ending Jun-13 3.50 7.12 3.62 103.37
Quarter Ending Dec-11 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Jun-15 -0.36 -0.38 0.02 -5.03
Quarter Ending Mar-15 -0.32 -0.13 0.19 -59.94
Quarter Ending Sep-14 -0.17 -0.45 0.27 -157.14
Quarter Ending Mar-14 -0.07 -0.16 0.09 -128.57
Quarter Ending Dec-13 -0.06 -0.04 0.02 -33.33

Consensus Estimates Trend

Sales and Profit Figures in Canadian Dollar (CAD)
Earnings and Dividend Figures in Canadian Dollar (CAD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Jun-16 0.00 0.00 1.67 7.91 7.91
Year Ending Jun-17 0.00 0.00 2.50 2.50 13.20
Earnings (per share)
Quarter Ending Mar-16 -0.08 -0.08 -0.08 -- --
Quarter Ending Jun-16 -0.08 -0.08 -0.08 -- --
Year Ending Jun-16 -0.38 -0.38 -0.35 -0.82 -0.85
Year Ending Jun-17 -1.20 -1.20 -1.05 -1.05 -1.22

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Jun-16 0 0 0 1
Year Ending Jun-17 0 0 0 1
Earnings
Quarter Ending Mar-16 0 0 0 0
Quarter Ending Jun-16 0 0 0 0
Year Ending Jun-16 0 0 1 1
Year Ending Jun-17 0 0 1 1

Analyst Research Reports

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$104.00
Provider : Reuters Investment Profile
$20.00
Provider : Pechala's Reports
$25.00
Provider : Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks